Literature DB >> 14624431

Late stent thrombosis after implantation of a sirolimus-eluting stent.

Arthur Kerner1, Luis Gruberg, Michael Kapeliovich, Ehud Grenadier.   

Abstract

Late stent thrombosis in the era of routine high-pressure stent deployment and combined antiplatelet therapy with thienopyridines and aspirin has become a rare but feared complication. We describe a patient with acute myocardial infarction due to late stent thrombosis 6 weeks after deployment of a sirolimus-eluting stent and 2 weeks after the discontinuation of clopidogrel. This is the first report of late thrombosis of a sirolimus-eluting stent. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624431     DOI: 10.1002/ccd.10712

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

1.  Very late thrombosis after implantation of sirolimus eluting stent.

Authors:  E Karvouni; S Korovesis; D G Katritsis
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  Late adverse events after drug-eluting stent implantation.

Authors:  David F Kong; Eric L Eisenstein; Robert Harrington
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

Review 3.  Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.

Authors:  Marco Zimarino; Giulia Renda; Raffaele De Caterina
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis.

Authors:  J M Ten Berg; J W van Werkum; A A C M Heestermans; W Jaarsma; R M A Hautvast; P den Heijer; M J de Boer
Journal:  Neth Heart J       Date:  2006-09       Impact factor: 2.380

Review 5.  Research and development strategy for biodegradable magnesium-based vascular stents: a review.

Authors:  Jialin Niu; Hua Huang; Jia Pei; Zhaohui Jin; Shaokang Guan; Guangyin Yuan
Journal:  Biomater Transl       Date:  2021-09-28

6.  Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.

Authors:  Shengsi Zhu; Hema Viswambharan; Thusitha Gajanayake; Xiu-Fen Ming; Zhihong Yang
Journal:  BMC Cardiovasc Disord       Date:  2005-07-15       Impact factor: 2.298

7.  Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography.

Authors:  B X Chen; F Y Ma; W Luo; J H Ruan; W L Xie; X Z Zhao; S H Sun; X M Guo; F Wang; T Tian; X W Chu
Journal:  Heart       Date:  2008-05       Impact factor: 5.994

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.